🔎 Trials Near Me

Home › Alzheimer's Disease › California › Concord

Alzheimer's Disease clinical trials in Concord, CA

5 studies for Alzheimer's Disease are looking for participants at sites in and around Concord (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

RecruitingPhase 2
  • Sunwise Clinical Research, Walnut Creek · 5 mi away
Ages 55 and older · All sexes · Updated Sep 29, 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

RecruitingPhase 3
  • Local Institution - 1651, Walnut Creek · 5 mi away
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

RecruitingPhase 3
  • Sunwise Clinical Research, Walnut Creek · 5 mi away
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011732

Senicapoc in Alzheimer's Disease

RecruitingPhase 2Healthy volunteers welcome
  • UC Davis Alzheimer's Disease Center East Bay, Walnut Creek · 5 mi away
Ages 55 to 85 · All sexes · Updated Aug 17, 2026 · NCT04804241

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

RecruitingPhase 3
  • Infectious Disease Doctors Medical Group, APC, Walnut Creek · 5 mi away
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582

About Alzheimer's Disease

Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.

More about Alzheimer's Disease on MedlinePlus

Alzheimer's Disease trials in other cities

Other studies in Concord

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.